Menu Search
Equities

Shandong Boan Biotechnology Co Ltd

UJ9:FRA

Shandong Boan Biotechnology Co Ltd

Actions
  • Price (EUR)1.07
  • Today's Change-0.03 / -2.73%
  • Shares traded-1.00
  • 1 Year change-39.55%
  • Beta--
Data delayed at least 15 minutes, as of May 29 2024 08:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shandong Boan Biotechnology Co Ltd is a China-based company primarily engaged in biopharmaceuticals. The Company is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The Company has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The Company operates mainly in the domestic Chinese market and overseas markets.

  • Revenue in HKD (TTM)666.14m
  • Net income in HKD-128.65m
  • Incorporated2013
  • Employees813.00
  • Location
    Shandong Boan Biotechnology Co LtdNo. 39 Keji AvenueHigh-Tech Industrial Development ZoneYANTAI ChinaCHN
  • Websitehttps://www.boan-bio.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.